Compound News and Research

RSS

Public voices often ignored in states’ opioid settlement money decisions

The conversation wasn't sounding good for Kensington residents on June 20. The Philadelphia neighborhood is a critical center of the nation's opioid crisis, and the city had decided to spend $7.5 million in opioid settlement money to improve the quality of life there.

27 Aug 2024

A novel approach to photosynthetic production of high-value compounds

Using evolution as a guiding principle, researchers have successfully engineered bacteria-yeast hybrids to perform photosynthetic carbon assimilation, generate cellular energy and support yeast growth without traditional carbon feedstocks like glucose or glycerol. By engineering photosynthetic cyanobacteria to live symbiotically inside yeast cells, the bacteria-yeast hybrids can produce important hydrocarbons, paving new biotechnical pathways to non-petroleum-based energy, other synthetic biology applications, and the experimental study of evolution.

27 Aug 2024

Austocystin D's anticancer efficacy linked to CYP2J2 enzyme activity

Austocystin D, a natural compound produced by fungi, has been recognized for its cytotoxic effects and anticancer activity in various cell types. It exhibits potent activity even in cells that express proteins associated with multidrug resistance, attracting significant global research interest.

27 Aug 2024

Pharmacy deserts disproportionately affect vulnerable communities across the U.S.

Nearly half of counties in the United States have at least one 'pharmacy desert' where there is no retail pharmacy within 10 miles, according to a new study published by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

23 Aug 2024

Innovative drug reduces inflammation in rats by inhibiting neutrophil activation

A newly developed compound that reduces harmful inflammation in rats caused by overactive neutrophils shows great potential as a safer treatment for various inflammatory diseases in humans.

23 Aug 2024

Cancer drug holds promise as a new treatment for neurodegenerative diseases

A type of drug developed for treating cancer holds promise as a new treatment for neurodegenerative diseases such as Alzheimer's, according to a recent study by researchers at Penn State, Stanford University and an international team of collaborators.

22 Aug 2024

The role of soy in improving metabolic health

Pennington Biomedical Research Center's Dr. Candida Rebello wants to know more about the intersection of blood sugar levels and a diet rich in soy. This intersection is the primary focus of her new study, "Lifestyle Intervention for Improving Metabolic and Motivational Outcomes," or MOTIVATE, which explores how specific diets can impact blood sugar, and potentially improve mood and energy levels.

22 Aug 2024

Breakthrough compound targets appetite and tau protein in obesity and Alzheimer's

Scientists on the team of Dr Lenka Maletínská have developed a promising new compound derived from one of the peptides naturally occurring in the brain.

21 Aug 2024

MolCompass: A breakthrough in identifying weak areas of chemical prediction models

In recent years, machine learning models have become increasingly popular for risk assessment of chemical compounds.

21 Aug 2024

New compound shows promise in Alzheimer’s preclinical models

A multidisciplinary team of scientists led by Kurt Brunden, Ph.D., at the University of Pennsylvania Perelman School of Medicine, and Carlo Ballatore, Ph.D., at University of California San Diego, has been awarded a $6.9 million grant from the National Institute on Aging (NIA) to prepare a potential disease-modifying Alzheimer's treatment for future clinical trials.

21 Aug 2024

Gut microbiome discovery paves the way for new heart failure treatments

Cleveland Clinic researchers have made a significant discovery about how the gut microbiome interacts with cells to cause cardiovascular disease.

20 Aug 2024

Study links gut microbe depletion to lifelong respiratory allergies

Researchers at the University of British Columbia have shown for the first time how and why the depletion of microbes in a newborn's gut by antibiotics can lead to lifelong respiratory allergies.

20 Aug 2024

NIH awards $6.9 million to prepare a potential Alzheimer's treatment for future clinical trials

A multidisciplinary team of scientists led by Carlo Ballatore, Ph.D., at University of California San Diego and Kurt Brunden, Ph.D., at the University of Pennsylvania has been awarded a $6.9 million grant from the National Institute on Aging (NIA) to prepare a potential disease-modifying Alzheimer's treatment for future clinical trials.

20 Aug 2024

How persistent organic pollutants affect gut health: findings on metabolic disruptions and microbiota changes

Early life exposure to potent AHR agonists on gut microbiota and its potential effects on metabolic health later in life.

20 Aug 2024

Researchers develop plant-based instant golden milk with enhanced shelf life

If you've visited a trendy café in the past few years, you might have noticed "golden" turmeric milk on the menu.

18 Aug 2024

Researchers use XAI to unlock secrets of drug discovery

Artificial intelligence (AI) has exploded in popularity. It powers models that help us drive vehicles, proofread emails and even design new molecules for medications.

18 Aug 2024

Scientists find way to restore brain's self-cleaning function

Alzheimer's, Parkinson's, and other neurological disorders can be seen as "dirty brain" diseases, where the brain struggles to clear out harmful waste. Aging is a key risk factor because, as we grow older, our brain's ability to remove toxic buildup slows down. However, new research in mice demonstrates that it's possible to reverse age-related effects and restore the brain's waste-clearing process.

16 Aug 2024

AlphaFold accelerates discovery of potential antipsychotic drugs by outperforming traditional methods

Researchers used AlphaFold and homology modeling to identify potent TAAR1 agonists, showing AlphaFold's superior performance in drug discovery for neuropsychiatric conditions.

13 Aug 2024

Researchers develop new method to study critical type of protein modification process

Human proteins undergo a variety of chemical modifications following their synthesis. These modifications regulate their structure, function, and stability.

12 Aug 2024

Insilico Medicine's pan-TEAD inhibitor ISM6331 receives FDA IND clearance for mesothelioma treatment

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced ISM6331, potential best-in-class pan-TEAD inhibitor, has received the U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) clearance for the treatment of mesothelioma, following the grant of Orphan Drug Designation (ODD) in June 2024. It brings the total number of IND-approved molecules of Insilico to nine.

8 Aug 2024

Compound News and Research

Public voices often ignored in states’ opioid settlement money decisions

A novel approach to photosynthetic production of high-value compounds

Austocystin D's anticancer efficacy linked to CYP2J2 enzyme activity

Pharmacy deserts disproportionately affect vulnerable communities across the U.S.

Innovative drug reduces inflammation in rats by inhibiting neutrophil activation

Cancer drug holds promise as a new treatment for neurodegenerative diseases

The role of soy in improving metabolic health

Breakthrough compound targets appetite and tau protein in obesity and Alzheimer's

MolCompass: A breakthrough in identifying weak areas of chemical prediction models

New compound shows promise in Alzheimer’s preclinical models

Gut microbiome discovery paves the way for new heart failure treatments

Study links gut microbe depletion to lifelong respiratory allergies

NIH awards $6.9 million to prepare a potential Alzheimer's treatment for future clinical trials

How persistent organic pollutants affect gut health: findings on metabolic disruptions and microbiota changes

Researchers develop plant-based instant golden milk with enhanced shelf life

Researchers use XAI to unlock secrets of drug discovery

Scientists find way to restore brain's self-cleaning function

AlphaFold accelerates discovery of potential antipsychotic drugs by outperforming traditional methods

Researchers develop new method to study critical type of protein modification process

Insilico Medicine's pan-TEAD inhibitor ISM6331 receives FDA IND clearance for mesothelioma treatment

Enhancing confidence in chemical ionization spectrometry data eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News